ICECREAM trial open to recruitment
Irinotecan Cetuximab Evaluation and the Cetuximab Response Evaluation Among Mutants: A randomised Phase II study of cetuximab... Read More
Irinotecan Cetuximab Evaluation and the Cetuximab Response Evaluation Among Mutants: A randomised Phase II study of cetuximab... Read More
6 – 8 September 2012 at the Sofitel Wentworth Sydney. Sessions included topics such as Refractory Colorectal Cancer;... Read More
Congratulations to the ‘Cancer can’t kill hope’ team that ran in the Sun-Herald Sydney City2Surf in August 2012.... Read More
Doctors have new treatments for advanced bowel cancer patients who are too ill to have chemotherapy. Professor John Simes from the Australasian Gastro-Intestinal Trials Group features in an ABC news article about the advanced bowel cancer treatments. This new discovery is said to be “providing patients with a greater choice of... Read More
Personalising cancer treatment for individuals is proving to be effective. Medical oncologist Professor Tim Price claims that by... Read More
By Anna Grummitt Mahmoud Chatila is an unstoppable 19-year-old from Melbourne who recently ran from Melbourne to Sydney in... Read More
Cancer Can’t Kill Hope – run for GI Cancer at this year’s City2Surf Running for the ‘Cancer can’t kill hope’ team in the Sydney City2Surf is a great way to keep healthy and help reduce your cancer risk – it also provides much needed funds for GI cancer trials. We... Read More